Skip to main content
. Author manuscript; available in PMC: 2013 Apr 1.
Published in final edited form as: Ann Rheum Dis. 2011 Nov 14;71(4):575–581. doi: 10.1136/annrheumdis-2011-200557

Figure 3. Rapamycin prevents reduction in cartilage cellularity during experimental OA.

Figure 3

A, Knee joint sections from C57Bl/6J mice with or without OA surgery under treatment with rapamycin (rapa) or vehicle (n=6 each) were stained with Hematoxylin Eosin (H&E). Magnification: 10× and 40×. B, Quantitative analysis of cell number showed a significant increase of cellularity after rapa treatment compared to vehicle treatment. Values are the mean ± SD. * = P < 0.001 versus OA-vehicle.